Hawaii Pacific Neuroscience — Honolulu, Hawaii

Hawaii Pacific Neuroscience is a clinical research site located in Honolulu, Hawaii, United States 96817.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Hawaii Pacific Neuroscience has participated in 49 clinical trials with 22 currently active.

Therapeutic areas: Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox-Gastaut Syndrome.

Sponsors: Longboard Pharmaceuticals, SK Life Science, Inc., Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hawaii Pacific Neuroscience?

Hawaii Pacific Neuroscience has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hawaii Pacific Neuroscience conducted?

Hawaii Pacific Neuroscience has 49 clinical trials on record, with 22 currently active. Their work covers Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox-Gastaut Syndrome.

Is Hawaii Pacific Neuroscience accredited by Crixeo Health?

Yes — Hawaii Pacific Neuroscience holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Hawaii Pacific Neuroscience?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.